20 Participants Needed

Powered Prosthetics for Knee Amputations

SF
LH
Overseen ByLevi Hargrove, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Shirley Ryan AbilityLab
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this study is to understand how providing power at the knee or ankle individually, or providing power at both the knee and ankle, impacts ambulation for K2 level transfemoral amputees. Aim 1: measure functional performance of K2 level ambulators when using a commercially available passive microprocessor knee prosthesis (Ottobock Cleg/Ottobock foot) or a powered knee and ankle prosthesis (SRALab Hybrid Knee and SRAlab Polycentric Powered Ankle. Aim 2: Participants will be evaluated on the contribution of adding power at the knee only or the ankle only. Aim 3: The investigators will evaluate the functional performance after intensive clinical gait training on the powered knee and ankle prosthesis (SRALab Hybrid Knee and SRALab Polycentric Powered Ankle). Our hypothesis is that providing powered componentry will improve function and that intensive training will magnify those improvements.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team or your doctor for guidance.

What data supports the effectiveness of the treatment SRALab Hybrid Knee and SRALab Polycentric Powered Ankle for knee amputations?

Research on similar powered prosthetic knees and ankles shows that they can help people with above-knee amputations walk more naturally and efficiently, even on stairs. Studies also suggest that these devices can improve walking speed and reduce the risk of falls, enhancing overall mobility and quality of life.12345

Is the powered prosthetic knee and ankle safe for humans?

The research indicates that powered prosthetic knees and ankles have been used safely in individuals with above-knee amputations, allowing them to walk and climb stairs with natural movements. While specific safety data is limited, the studies suggest these devices can be configured effectively for different walking modes, potentially making them a viable option for improving mobility.46789

How does the SRALab Hybrid Knee and SRALab Polycentric Powered Ankle treatment differ from other treatments for knee amputations?

The SRALab Hybrid Knee and SRALab Polycentric Powered Ankle treatment is unique because it combines powered components that replicate natural leg movements, enabling more natural walking and stair climbing for individuals with knee amputations. Unlike passive prostheses, these powered devices can generate positive knee power and restore natural ankle push-off, improving functional mobility and quality of life.1241011

Eligibility Criteria

This trial is for K2-level transfemoral amputees, meaning individuals who have had an above-knee amputation and can walk with a cane or crutches. The study aims to understand the impact of powered prosthetic knees and ankles on their walking ability.

Inclusion Criteria

It has been over 6 months since I got my final prosthesis.
I have had one leg amputated above the knee.
Medically cleared by physician to participate in study
See 2 more

Exclusion Criteria

I understand and can follow the study's requirements.
I weigh more than 250 pounds.
Significant other comorbidity
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Baseline data collection with Ottobock Cleg 4/Ottobock foot or clinically prescribed microprocessor knee unit/foot

1 week
1 visit (in-person)

Condition A: CLeg + Polycentric Ankle

Participants are fit with the CLeg + Polycentric Ankle and undergo device tuning and functional outcome assessments

3 weeks
4 visits (in-person)

Condition B: SRALab Hybrid Knee + Passive Ankle

Participants switch to SRALab Hybrid Knee + Passive Ankle and repeat the protocol for device tuning and assessments

3 weeks
4 visits (in-person)

Intensive Training

Participants receive intensive clinical training with the SRALab Hybrid Knee + Polycentric Ankle

8 weeks
16 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks
2 visits (in-person)

Treatment Details

Interventions

  • SRALab Hybrid Knee and SRALab Polycentric Powered Ankle
Trial Overview The study compares different combinations of prosthetic limbs: a passive microprocessor knee (Ottobock CLeg4) with either an Ottobock foot or polycentric ankle, and a powered knee (SRALAB Hybrid Knee) with either a passive or polycentric powered ankle.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Transfemoral Amputee participants: SRALAB Hybrid knee + Polycentric Ankle, Ottobock Cleg4 + OB footExperimental Treatment2 Interventions
During this arm, participants will receive intensive clinical training with the SRALAB Hybrid knee + Polycentric Ankle twice per week over 8 weeks, lasting 2-3 hours. Training will include patient-driven therapy to achieve participants' individual therapy goals, functional mobility and community skills. At the end of the 8-week training period, subjects will complete the same set of functional outcome measures, biomechanical and metabolic assessments in previous arms. To complete this arm, participants will again complete training and outcome measures with the Ottobock Cleg4/Ottobock or their clinically prescribed microprocessor knee unit/foot over 3 visits.
Group II: Transfemoral Amputee participants: Ottobock CLeg4 + Polycentric Ankle, Hybrid Knee + Passive AnkleExperimental Treatment2 Interventions
For this arm, transfemoral amputees will participate in an AB/BA randomized crossover study. Before each arm of the cross-over, baseline data will be taken with the Ottobock Cleg 4/Ottobock foot or their clinically prescribed microprocessor knee unit/foot. Condition A is CLeg + Polycentric Ankle Condition B is SRALab Hybrid knee + Passive Ankle Subjects will participate in 2 sessions over 2 weeks, each lasting 2-3 hours to have the device tuned for the specific condition (A or B). On the third week, they will participate in 2 visits to complete functional outcome measures, biomechanical and metabolic assessments. They will then switch conditions, and repeat the protocol for the second condition. There will not be a washout period between conditions, but subjects will complete outcome measures with the Ottobock Cleg 4/Ottobock foot or their clinically prescribed microprocessor knee unit/foot prior to each arm of the crossover to obtain baseline data.
Group III: Transfemoral Amputee participants: Ottobock Cleg4 + Ottobock foot; Hybrid Knee + Polycentric AnkleActive Control2 Interventions
Participant is fit with the commercially available device (Ottobock Cleg 4/Ottobock foot), they will receive standard of care clinical training for 3-4 sessions over 4 weeks, plus 1 session for outcome assessments. Participant is then fit with the SRALAB Hybrid knee and SRALAB Polycentric Ankle prosthesis, they again will receive clinical training for 3-4 sessions over 4 weeks, plus 1 session for outcome assessments.

SRALab Hybrid Knee and SRALab Polycentric Powered Ankle is already approved in United States for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as SRALab Hybrid Knee and SRALab Polycentric Powered Ankle for:
  • Transfemoral amputation for K2 level ambulators

Find a Clinic Near You

Who Is Running the Clinical Trial?

Shirley Ryan AbilityLab

Lead Sponsor

Trials
212
Recruited
17,900+

Findings from Research

In a study involving 20 male above-knee amputees fitted with a new UCBL four-bar polycentric knee prosthesis, 16 participants reported benefits from the device, with 7 considering it superior to their previous prosthetics after an average follow-up of 12.3 months.
Most subjects experienced maintained or enhanced functionality, particularly noting improved ease of walking on inclines and increased knee flexion, although some initial mechanical issues were resolved during the study.
Subjective evaluation of the UCBL polycentric knee linkage by active above knee amputees. A prospective trial.Jergesen, HE., Hoaglund, FT., Roberts, RA.[2022]
In a clinical trial involving 20 active above-knee amputees, 80% reported positive experiences with the UCBL four-bar polycentric prosthetic knee, with over one-third finding it superior to previous devices.
The prosthetic knee allowed for increased knee flexion, helping to maintain or enhance daily activity levels without significantly altering fundamental gait parameters, indicating its potential effectiveness and safety for users.
The University of California Biomechanics Laboratory four-bar polycentric knee linkage. A clinical trial in 20 active above-knee amputees.Jergesen, HE., Hoaglund, FT., Roberts, RA., et al.[2022]
Microprocessor-controlled prosthetic knees (MPKs) can significantly reduce uncontrolled falls by up to 80% and improve fall risk indicators for individuals with transfemoral amputation classified as MFCL-2, based on a review of six studies involving 57 subjects.
Users of MPKs may experience improved walking speeds, with a 14% to 25% increase on level ground, a 20% increase on uneven surfaces, and a nearly 30% faster descent on slopes, suggesting enhanced mobility and safety for limited community ambulators.
Benefits of microprocessor-controlled prosthetic knees to limited community ambulators: systematic review.Kannenberg, A., Zacharias, B., Prรถbsting, E.[2022]

References

Subjective evaluation of the UCBL polycentric knee linkage by active above knee amputees. A prospective trial. [2022]
The University of California Biomechanics Laboratory four-bar polycentric knee linkage. A clinical trial in 20 active above-knee amputees. [2022]
Benefits of microprocessor-controlled prosthetic knees to limited community ambulators: systematic review. [2022]
Powered knee and ankle prostheses enable natural ambulation on level ground and stairs for individuals with bilateral above-knee amputation: a case study. [2023]
Gait efficiency using the C-Leg. [2022]
Advanced techniques in amputation surgery and prosthetic technology in the lower extremity. [2020]
[Evolution in prostheses for sprinters with lower-limb amputation]. [2022]
Functional Performance Outcomes of a Powered Knee-Ankle Prosthesis in Service Members With Unilateral Transfemoral Limb Loss. [2023]
Configuring a powered knee and ankle prosthesis for transfemoral amputees within five specific ambulation modes. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Assessment of transfemoral amputees using C-Leg and Power Knee for ascending and descending inclines and steps. [2019]
Comparison of the Power Knee and C-Leg during step-up and sit-to-stand tasks. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity